Edesa Biotech, Inc.
Q1 2025 13F Holders
Symbol
EDSA
CUSIP
27966L306
Type
Equity
Class
COM NEW
Num filings
20
Total reported value, excl. options
$6.89 M
Compare 2025 Q1 to
2025 Q2
2024 Q4
2024 Q3
2024 Q2
2024 Q1
2023 Q4
Manager
Report Date
Value ($000)
Shares
Option Type